Schonfeld Strategic Advisors’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-11,300
| Closed | -$68K | – | 3091 |
|
|
2022
Q3 | $68K | Sell |
11,300
-100
| -0.9% | -$602 | ﹤0.01% | 2547 |
|
|
2022
Q2 | $47K | Sell |
11,400
-10,100
| -47% | -$41.6K | ﹤0.01% | 2150 |
|
|
2022
Q1 | $81K | Buy |
21,500
+7,500
| +54% | +$28.3K | ﹤0.01% | 2208 |
|
|
2021
Q4 | $63K | Sell |
14,000
-200
| -1% | -$900 | ﹤0.01% | 1864 |
|
|
2021
Q3 | $67K | Buy |
+14,200
| New | +$67K | ﹤0.01% | 1889 |
|
|
2021
Q2 | – | Sell |
-14,400
| Closed | -$86K | – | 2379 |
|
|
2021
Q1 | $86K | Sell |
14,400
-1,200
| -8% | -$7.17K | ﹤0.01% | 1640 |
|
|
2020
Q4 | $72K | Buy |
+15,600
| New | +$72K | ﹤0.01% | 1440 |
|
|
2020
Q3 | – | Sell |
-11,000
| Closed | -$317K | – | 1694 |
|
|
2020
Q2 | $317K | Buy |
+11,000
| New | +$317K | 0.01% | 931 |
|